Breast cancer statistics, 2013
In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 232,340 new cases of invasive breast cancer and 39,620 breast cancer deaths are expected to occur...
Uloženo v:
| Vydáno v: | CA: a cancer journal for clinicians Ročník 64; číslo 1; s. 52 - 62 |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Journal Article |
| Jazyk: | angličtina |
| Vydáno: |
United States
Wiley Subscription Services, Inc
01.01.2014
|
| Témata: | |
| ISSN: | 0007-9235, 1542-4863, 1542-4863 |
| On-line přístup: | Získat plný text |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
| Abstract | In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 232,340 new cases of invasive breast cancer and 39,620 breast cancer deaths are expected to occur among US women in 2013. One in 8 women in the United States will develop breast cancer in her lifetime. Breast cancer incidence rates increased slightly among African American women; decreased among Hispanic women; and were stable among whites, Asian Americans/Pacific Islanders, and American Indians/Alaska Natives from 2006 to 2010. Historically, white women have had the highest breast cancer incidence rates among women aged 40 years and older; however, incidence rates are converging among white and African American women, particularly among women aged 50 years to 59 years. Incidence rates increased for estrogen receptor‐positive breast cancers in the youngest white women, Hispanic women aged 60 years to 69 years, and all but the oldest African American women. In contrast, estrogen receptor‐negative breast cancers declined among most age and racial/ethnic groups. These divergent trends may reflect etiologic heterogeneity and the differing effects of some factors, such as obesity and parity, on risk by tumor subtype. Since 1990, breast cancer death rates have dropped by 34% and this decrease was evident in all racial/ethnic groups except American Indians/Alaska Natives. Nevertheless, survival disparities persist by race/ethnicity, with African American women having the poorest breast cancer survival of any racial/ethnic group. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high‐quality screening, diagnosis, and treatment to all segments of the population. CA Cancer J Clin 2014;64:52–62. © 2013 American Cancer Society, Inc. |
|---|---|
| AbstractList | In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 232,340 new cases of invasive breast cancer and 39,620 breast cancer deaths are expected to occur among US women in 2013. One in 8 women in the United States will develop breast cancer in her lifetime. Breast cancer incidence rates increased slightly among African American women; decreased among Hispanic women; and were stable among whites, Asian Americans/Pacific Islanders, and American Indians/Alaska Natives from 2006 to 2010. Historically, white women have had the highest breast cancer incidence rates among women aged 40 years and older; however, incidence rates are converging among white and African American women, particularly among women aged 50 years to 59 years. Incidence rates increased for estrogen receptor‐positive breast cancers in the youngest white women, Hispanic women aged 60 years to 69 years, and all but the oldest African American women. In contrast, estrogen receptor‐negative breast cancers declined among most age and racial/ethnic groups. These divergent trends may reflect etiologic heterogeneity and the differing effects of some factors, such as obesity and parity, on risk by tumor subtype. Since 1990, breast cancer death rates have dropped by 34% and this decrease was evident in all racial/ethnic groups except American Indians/Alaska Natives. Nevertheless, survival disparities persist by race/ethnicity, with African American women having the poorest breast cancer survival of any racial/ethnic group. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high‐quality screening, diagnosis, and treatment to all segments of the population. CA Cancer J Clin 2014;64:52–62. © 2013 American Cancer Society, Inc. In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 232,340 new cases of invasive breast cancer and 39,620 breast cancer deaths are expected to occur among US women in 2013. One in 8 women in the United States will develop breast cancer in her lifetime. Breast cancer incidence rates increased slightly among African American women; decreased among Hispanic women; and were stable among whites, Asian Americans/Pacific Islanders, and American Indians/Alaska Natives from 2006 to 2010. Historically, white women have had the highest breast cancer incidence rates among women aged 40 years and older; however, incidence rates are converging among white and African American women, particularly among women aged 50 years to 59 years. Incidence rates increased for estrogen receptor-positive breast cancers in the youngest white women, Hispanic women aged 60 years to 69 years, and all but the oldest African American women. In contrast, estrogen receptor-negative breast cancers declined among most age and racial/ethnic groups. These divergent trends may reflect etiologic heterogeneity and the differing effects of some factors, such as obesity and parity, on risk by tumor subtype. Since 1990, breast cancer death rates have dropped by 34% and this decrease was evident in all racial/ethnic groups except American Indians/Alaska Natives. Nevertheless, survival disparities persist by race/ethnicity, with African American women having the poorest breast cancer survival of any racial/ethnic group. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high-quality screening, diagnosis, and treatment to all segments of the population.In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 232,340 new cases of invasive breast cancer and 39,620 breast cancer deaths are expected to occur among US women in 2013. One in 8 women in the United States will develop breast cancer in her lifetime. Breast cancer incidence rates increased slightly among African American women; decreased among Hispanic women; and were stable among whites, Asian Americans/Pacific Islanders, and American Indians/Alaska Natives from 2006 to 2010. Historically, white women have had the highest breast cancer incidence rates among women aged 40 years and older; however, incidence rates are converging among white and African American women, particularly among women aged 50 years to 59 years. Incidence rates increased for estrogen receptor-positive breast cancers in the youngest white women, Hispanic women aged 60 years to 69 years, and all but the oldest African American women. In contrast, estrogen receptor-negative breast cancers declined among most age and racial/ethnic groups. These divergent trends may reflect etiologic heterogeneity and the differing effects of some factors, such as obesity and parity, on risk by tumor subtype. Since 1990, breast cancer death rates have dropped by 34% and this decrease was evident in all racial/ethnic groups except American Indians/Alaska Natives. Nevertheless, survival disparities persist by race/ethnicity, with African American women having the poorest breast cancer survival of any racial/ethnic group. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high-quality screening, diagnosis, and treatment to all segments of the population. In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 232,340 new cases of invasive breast cancer and 39,620 breast cancer deaths are expected to occur among US women in 2013. One in 8 women in the United States will develop breast cancer in her lifetime. Breast cancer incidence rates increased slightly among African American women; decreased among Hispanic women; and were stable among whites, Asian Americans/Pacific Islanders, and American Indians/Alaska Natives from 2006 to 2010. Historically, white women have had the highest breast cancer incidence rates among women aged 40 years and older; however, incidence rates are converging among white and African American women, particularly among women aged 50 years to 59 years. Incidence rates increased for estrogen receptor-positive breast cancers in the youngest white women, Hispanic women aged 60 years to 69 years, and all but the oldest African American women. In contrast, estrogen receptor-negative breast cancers declined among most age and racial/ethnic groups. These divergent trends may reflect etiologic heterogeneity and the differing effects of some factors, such as obesity and parity, on risk by tumor subtype. Since 1990, breast cancer death rates have dropped by 34% and this decrease was evident in all racial/ethnic groups except American Indians/Alaska Natives. Nevertheless, survival disparities persist by race/ethnicity, with African American women having the poorest breast cancer survival of any racial/ethnic group. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high-quality screening, diagnosis, and treatment to all segments of the population. [PUBLICATION ABSTRACT] In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence, mortality, survival, and screening. Approximately 232,340 new cases of invasive breast cancer and 39,620 breast cancer deaths are expected to occur among US women in 2013. One in 8 women in the United States will develop breast cancer in her lifetime. Breast cancer incidence rates increased slightly among African American women; decreased among Hispanic women; and were stable among whites, Asian Americans/Pacific Islanders, and American Indians/Alaska Natives from 2006 to 2010. Historically, white women have had the highest breast cancer incidence rates among women aged 40 years and older; however, incidence rates are converging among white and African American women, particularly among women aged 50 years to 59 years. Incidence rates increased for estrogen receptor-positive breast cancers in the youngest white women, Hispanic women aged 60 years to 69 years, and all but the oldest African American women. In contrast, estrogen receptor-negative breast cancers declined among most age and racial/ethnic groups. These divergent trends may reflect etiologic heterogeneity and the differing effects of some factors, such as obesity and parity, on risk by tumor subtype. Since 1990, breast cancer death rates have dropped by 34% and this decrease was evident in all racial/ethnic groups except American Indians/Alaska Natives. Nevertheless, survival disparities persist by race/ethnicity, with African American women having the poorest breast cancer survival of any racial/ethnic group. Continued progress in the control of breast cancer will require sustained and increased efforts to provide high-quality screening, diagnosis, and treatment to all segments of the population. |
| Author | Jemal, Ahmedin Ma, Jiemin Bryan, Leah DeSantis, Carol |
| Author_xml | – sequence: 1 givenname: Carol surname: DeSantis fullname: DeSantis, Carol organization: Surveillance and Health Services Research, American Cancer Society – sequence: 2 givenname: Jiemin surname: Ma fullname: Ma, Jiemin organization: Surveillance and Health Services Research, American Cancer Society – sequence: 3 givenname: Leah surname: Bryan fullname: Bryan, Leah organization: Surveillance and Health Services Research, American Cancer Society – sequence: 4 givenname: Ahmedin surname: Jemal fullname: Jemal, Ahmedin organization: Surveillance and Health Services Research, American Cancer Society |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/24114568$$D View this record in MEDLINE/PubMed |
| BookMark | eNp90F1LwzAUBuAgE_ehN_6AMfBGxM5zkrRpLmvxCwbe6HVIsxQ6unYmLbJ_b2unF0O8CgnPe8h5p2RU1ZUl5BJhyRild0Zrs6RIgZ2QCYacBjyO2IhMAEAEkrJwTKbeb6C_C3FGxpQj8jCKJ2R-76z2zcLoyli38I1uCt8Uxt8uKCA7J6e5Lr29OJwz8v748JY-B6vXp5c0WQWGh5IFAmLOWC7XmYBImgxyjHIG0toIsnwdxTTGTIYatASNOVBKs-6dcW4iE6NgM3I9zN25-qO1vlHbwhtblrqydesVcgkCkVHe0asjuqlbV3W_6xVyKsIYOzU_qDbb2rXauWKr3V79bN6BmwEYV3vvbP5LEFRfq-prVd-1dhiOsCn6puqqcboo_47gEPksSrv_Z7hKkyQdMl9Sy4Sb |
| CODEN | CAMCAM |
| CitedBy_id | crossref_primary_10_1007_s12262_018_1830_4 crossref_primary_10_1111_ecc_13722 crossref_primary_10_1016_j_cmpb_2021_106612 crossref_primary_10_1016_j_maturitas_2014_06_015 crossref_primary_10_1155_2022_1350813 crossref_primary_10_3390_cancers14184484 crossref_primary_10_31083_j_fbl2903099 crossref_primary_10_1007_s13277_016_5421_3 crossref_primary_10_1186_s43045_021_00165_x crossref_primary_10_1111_ijcp_13897 crossref_primary_10_3390_ijms21239125 crossref_primary_10_3892_mmr_2019_10044 crossref_primary_10_1038_s41598_018_24961_4 crossref_primary_10_1073_pnas_2210618119 crossref_primary_10_1016_j_cyto_2018_03_020 crossref_primary_10_3892_ol_2019_10137 crossref_primary_10_1007_s12094_019_02155_2 crossref_primary_10_1186_s41120_018_0025_1 crossref_primary_10_1155_2015_231656 crossref_primary_10_1007_s00428_016_1903_3 crossref_primary_10_3389_fgene_2019_00278 crossref_primary_10_1016_j_bspc_2019_02_019 crossref_primary_10_1016_j_colsurfa_2018_12_026 crossref_primary_10_3892_or_2015_3796 crossref_primary_10_1002_cncr_29194 crossref_primary_10_1186_s12935_022_02611_0 crossref_primary_10_1155_2015_761820 crossref_primary_10_1158_0008_5472_CAN_17_0709 crossref_primary_10_14712_fb2019065010024 crossref_primary_10_3390_jcm11164662 crossref_primary_10_1097_GOX_0000000000002619 crossref_primary_10_3892_mmr_2019_10033 crossref_primary_10_3892_ol_2018_9214 crossref_primary_10_1016_j_canep_2015_10_025 crossref_primary_10_1186_s12301_021_00224_z crossref_primary_10_1586_14737140_2015_961429 crossref_primary_10_3389_fonc_2021_679367 crossref_primary_10_1016_j_intimp_2021_108430 crossref_primary_10_1016_j_psc_2023_04_010 crossref_primary_10_1371_journal_pone_0260533 crossref_primary_10_1371_journal_pone_0219093 crossref_primary_10_1007_s12253_017_0246_y crossref_primary_10_1007_s00066_018_1346_7 crossref_primary_10_1007_s12194_019_00500_2 crossref_primary_10_1111_jcmm_12740 crossref_primary_10_1016_j_hpb_2016_07_003 crossref_primary_10_3390_jfmk3010009 crossref_primary_10_1186_s12885_018_4207_y crossref_primary_10_1002_cam4_447 crossref_primary_10_1155_2019_8637895 crossref_primary_10_1038_s41419_019_1440_5 crossref_primary_10_1188_15_CJON_E52_E58 crossref_primary_10_1177_0962280218765007 crossref_primary_10_1007_s10396_016_0724_y crossref_primary_10_3390_ijms26104894 crossref_primary_10_1080_15384047_2018_1456599 crossref_primary_10_1007_s12032_016_0732_1 crossref_primary_10_1093_annonc_mdv590 crossref_primary_10_1016_j_canrad_2021_12_002 crossref_primary_10_1002_advs_202200681 crossref_primary_10_1007_s12609_016_0223_6 crossref_primary_10_1007_s12013_014_0459_6 crossref_primary_10_1016_j_pec_2015_09_014 crossref_primary_10_3233_CBM_171124 crossref_primary_10_1038_srep10433 crossref_primary_10_1158_0008_5472_CAN_15_3332 crossref_primary_10_1007_s42979_021_00452_8 crossref_primary_10_1007_s11307_015_0902_0 crossref_primary_10_21303_2504_5679_2019_00882 crossref_primary_10_1111_febs_15373 crossref_primary_10_1016_j_neubiorev_2017_10_011 crossref_primary_10_1002_cjp2_25 crossref_primary_10_1007_s11010_018_3281_4 crossref_primary_10_1097_GOX_0000000000001341 crossref_primary_10_1158_0008_5472_CAN_17_0914 crossref_primary_10_1007_s10549_015_3363_x crossref_primary_10_1016_j_tiv_2015_09_009 crossref_primary_10_1097_MD_0000000000024827 crossref_primary_10_1016_j_tcb_2017_11_001 crossref_primary_10_1016_j_radcr_2018_08_029 crossref_primary_10_3892_ol_2017_7204 crossref_primary_10_1002_adhm_201900203 crossref_primary_10_3389_fonc_2021_687190 crossref_primary_10_1186_s12967_015_0521_1 crossref_primary_10_1007_s10549_019_05418_2 crossref_primary_10_1200_JCO_2016_71_7439 crossref_primary_10_1016_j_breast_2020_02_011 crossref_primary_10_1002_jcb_27738 crossref_primary_10_3389_fcell_2021_798221 crossref_primary_10_3390_molecules24152753 crossref_primary_10_3390_jpm11121361 crossref_primary_10_1042_BSR20150167 crossref_primary_10_1089_dna_2021_0866 crossref_primary_10_1016_j_bbrc_2016_07_054 crossref_primary_10_5888_pcd15_180177 crossref_primary_10_3390_molecules200712481 crossref_primary_10_1080_14740338_2016_1192604 crossref_primary_10_1186_s12964_019_0348_0 crossref_primary_10_1155_2015_842091 crossref_primary_10_1186_s12905_017_0456_1 crossref_primary_10_1007_s00044_025_03383_8 crossref_primary_10_1039_C9RA04380B crossref_primary_10_1016_j_jacr_2018_11_019 crossref_primary_10_1056_NEJMoa2104162 crossref_primary_10_1002_jcb_25564 crossref_primary_10_3892_ijo_2014_2591 crossref_primary_10_1016_j_compbiomed_2020_104089 crossref_primary_10_1016_j_canlet_2020_11_047 crossref_primary_10_1038_srep08582 crossref_primary_10_2147_OTT_S261461 crossref_primary_10_1038_bjc_2015_466 crossref_primary_10_3892_etm_2019_7206 crossref_primary_10_1188_14_ONF_639_646 crossref_primary_10_1016_j_prp_2019_152524 crossref_primary_10_3389_fonc_2024_1424569 crossref_primary_10_1186_s13148_019_0620_6 crossref_primary_10_1371_journal_pone_0167976 crossref_primary_10_1002_fsn3_1154 crossref_primary_10_3390_ijms24032804 crossref_primary_10_1309_AJCPYO5FSV3UPEXS crossref_primary_10_2147_CMAR_S299066 crossref_primary_10_3389_fonc_2023_1031682 crossref_primary_10_1016_j_mce_2016_10_003 crossref_primary_10_1093_carcin_bgw077 crossref_primary_10_1016_j_jacr_2018_12_020 crossref_primary_10_1097_HRP_0000000000000071 crossref_primary_10_3892_mmr_2015_3426 crossref_primary_10_1016_j_poly_2021_115504 crossref_primary_10_3390_ijerph14050486 crossref_primary_10_3390_medicina56060281 crossref_primary_10_1038_nrclinonc_2017_74 crossref_primary_10_1038_s41419_023_06148_6 crossref_primary_10_1111_bcp_13661 crossref_primary_10_1016_j_annepidem_2014_09_006 crossref_primary_10_1093_annonc_mdv379 crossref_primary_10_1097_GOX_0000000000001798 crossref_primary_10_1155_2016_7128702 crossref_primary_10_5493_wjem_v5_i3_194 crossref_primary_10_1007_s00266_016_0612_2 crossref_primary_10_3892_mmr_2018_8398 crossref_primary_10_1016_j_mce_2021_111245 crossref_primary_10_1155_2021_7879508 crossref_primary_10_1007_s13277_015_3746_y crossref_primary_10_1007_s13277_015_4039_1 crossref_primary_10_1016_j_molimm_2017_10_003 crossref_primary_10_1111_papr_13004 crossref_primary_10_3389_fendo_2021_766463 crossref_primary_10_1109_TUFFC_2014_006886 crossref_primary_10_3389_fonc_2022_957511 crossref_primary_10_1245_s10434_015_4668_z crossref_primary_10_1002_jemt_23275 crossref_primary_10_1007_s12609_018_0277_8 crossref_primary_10_3389_fgene_2016_00170 crossref_primary_10_3892_ol_2022_13449 crossref_primary_10_1111_cas_12699 crossref_primary_10_1007_s10585_018_9935_5 crossref_primary_10_1016_j_annepidem_2018_03_019 crossref_primary_10_1177_000313481708300840 crossref_primary_10_1007_s10585_017_9871_9 crossref_primary_10_36290_xon_2024_043 crossref_primary_10_1007_s40778_018_0123_y crossref_primary_10_1007_s13277_014_2510_z crossref_primary_10_1016_j_biopha_2015_07_038 crossref_primary_10_1016_j_fct_2023_113855 crossref_primary_10_1038_s41598_018_34604_3 crossref_primary_10_1093_jbi_wbad054 crossref_primary_10_1159_000494765 crossref_primary_10_1186_s12935_019_0885_z crossref_primary_10_1186_s42077_022_00239_w crossref_primary_10_1016_j_pdpdt_2021_102575 crossref_primary_10_3233_BD_201021 crossref_primary_10_31083_j_fbl2806129 crossref_primary_10_1093_jnci_dju165 crossref_primary_10_1016_j_molimm_2017_03_007 crossref_primary_10_1245_s10434_020_09123_z crossref_primary_10_3390_jcm9010209 crossref_primary_10_1371_journal_pone_0269998 crossref_primary_10_1515_chem_2024_0064 crossref_primary_10_1080_15384101_2016_1190892 crossref_primary_10_1111_php_13482 crossref_primary_10_3727_096504016X14732772150505 crossref_primary_10_1016_j_jss_2014_02_018 crossref_primary_10_1016_j_remnie_2016_01_011 crossref_primary_10_1007_s10549_015_3334_2 crossref_primary_10_1186_s12906_019_2615_4 crossref_primary_10_1016_j_gene_2016_11_037 crossref_primary_10_1016_j_taap_2016_09_019 crossref_primary_10_1111_1759_7714_14238 crossref_primary_10_1016_j_intimp_2016_03_002 crossref_primary_10_3892_etm_2014_1999 crossref_primary_10_1016_j_acra_2017_05_021 crossref_primary_10_1002_iub_1494 crossref_primary_10_1002_jcp_25514 crossref_primary_10_1007_s11626_018_0282_2 crossref_primary_10_3322_caac_21320 crossref_primary_10_3892_or_2016_5192 crossref_primary_10_1007_s11042_018_6026_1 crossref_primary_10_1111_jcmm_16945 crossref_primary_10_1016_j_amepre_2015_07_020 crossref_primary_10_1186_s12885_016_2750_y crossref_primary_10_4137_CIN_S40300 crossref_primary_10_1097_PRS_0000000000005313 crossref_primary_10_1177_02841851231177379 crossref_primary_10_1371_journal_pone_0149279 crossref_primary_10_3892_ol_2017_5644 crossref_primary_10_5604_01_3001_0009_5480 crossref_primary_10_1007_s10549_017_4278_5 crossref_primary_10_1111_cas_13572 crossref_primary_10_1016_j_reprotox_2014_10_019 crossref_primary_10_1186_s12935_022_02528_8 crossref_primary_10_1038_s41598_024_78490_4 crossref_primary_10_1007_s12094_017_1650_1 crossref_primary_10_1016_j_asjsur_2016_02_003 crossref_primary_10_1080_10408398_2016_1263597 crossref_primary_10_1007_s10637_019_00837_w crossref_primary_10_1016_j_jddst_2023_105175 crossref_primary_10_1093_nar_gkv922 crossref_primary_10_1016_j_ijpharm_2018_10_048 crossref_primary_10_1038_s41419_018_1210_9 crossref_primary_10_3389_fgene_2015_00072 crossref_primary_10_1002_jso_25901 crossref_primary_10_1073_pnas_1615015114 crossref_primary_10_3390_cells9081855 crossref_primary_10_1002_jbm4_10125 crossref_primary_10_3892_mmr_2017_7603 crossref_primary_10_3892_or_2015_3979 crossref_primary_10_1007_s12672_023_00809_w crossref_primary_10_3389_fphar_2021_824531 crossref_primary_10_1016_j_biomaterials_2016_12_019 crossref_primary_10_1007_s00210_024_03579_6 crossref_primary_10_3390_cancers12092553 crossref_primary_10_1002_ardp_202100177 crossref_primary_10_1016_j_prp_2018_04_003 crossref_primary_10_1080_14756366_2018_1452919 crossref_primary_10_1093_humrep_deac109 crossref_primary_10_1245_s10434_015_4755_1 crossref_primary_10_1159_000508138 crossref_primary_10_1002_path_4716 crossref_primary_10_1111_cas_13588 crossref_primary_10_1155_2020_3617514 crossref_primary_10_3892_mmr_2016_4901 crossref_primary_10_1007_s10549_015_3554_5 crossref_primary_10_5812_ijcm_85822 crossref_primary_10_1007_s10549_023_06925_z crossref_primary_10_1007_s00280_016_2959_0 crossref_primary_10_1080_00914037_2017_1393678 crossref_primary_10_1200_JCO_2016_70_5400 crossref_primary_10_1002_cncr_29607 crossref_primary_10_1002_mc_22602 crossref_primary_10_1093_annonc_mdv330 crossref_primary_10_1111_nyas_14916 crossref_primary_10_1016_j_amjsurg_2016_06_010 crossref_primary_10_1007_s40615_019_00591_y crossref_primary_10_1177_22808000221092157 crossref_primary_10_2478_fco_2024_0009 crossref_primary_10_1007_s00404_018_4982_3 crossref_primary_10_1016_j_biopha_2018_05_058 crossref_primary_10_1007_s10552_014_0481_4 crossref_primary_10_1097_GOX_0000000000006867 crossref_primary_10_3892_mmr_2015_3480 crossref_primary_10_1142_S0192415X21500233 crossref_primary_10_3892_mmr_2018_9419 crossref_primary_10_1007_s00520_020_05521_x crossref_primary_10_1186_2241_5793_21_14 crossref_primary_10_5812_jkums_133836 crossref_primary_10_1002_wps_20204 crossref_primary_10_1016_j_phpro_2015_03_012 crossref_primary_10_1007_s11696_017_0190_z crossref_primary_10_1098_rsos_240962 crossref_primary_10_3389_fsurg_2021_696628 crossref_primary_10_3390_cancers14184461 crossref_primary_10_1155_2015_279601 crossref_primary_10_1002_cam4_5755 crossref_primary_10_3390_cancers13122922 crossref_primary_10_1002_jso_23990 crossref_primary_10_1016_j_colcom_2023_100739 crossref_primary_10_18632_oncotarget_7043 crossref_primary_10_1038_cddis_2014_499 crossref_primary_10_1177_0284185119858040 crossref_primary_10_7759_cureus_50887 crossref_primary_10_1053_j_sart_2022_04_005 crossref_primary_10_1016_j_lpm_2015_10_017 crossref_primary_10_1177_1176935117746644 crossref_primary_10_1590_1806_9282_63_01_35 crossref_primary_10_1186_s13072_018_0203_3 crossref_primary_10_1007_s00330_020_07181_1 crossref_primary_10_3390_ijms160511728 crossref_primary_10_1093_mtomcs_mfac052 crossref_primary_10_1097_CAD_0000000000000968 crossref_primary_10_1007_s13277_015_4402_2 crossref_primary_10_1016_j_bjps_2015_02_027 crossref_primary_10_1111_1759_7714_14401 crossref_primary_10_1371_journal_pone_0132824 crossref_primary_10_3389_fonc_2021_715554 crossref_primary_10_3390_s22093594 crossref_primary_10_3390_diagnostics12020456 crossref_primary_10_1007_s11094_022_02713_z crossref_primary_10_3390_cancers10090282 crossref_primary_10_1007_s10585_015_9710_9 crossref_primary_10_1007_s11042_022_12859_3 crossref_primary_10_1007_s12609_018_0266_y crossref_primary_10_1080_01635581_2025_2474262 crossref_primary_10_2147_IJN_S248736 crossref_primary_10_1080_07357907_2016_1270957 crossref_primary_10_1245_s10434_014_4205_5 crossref_primary_10_3390_ijms23179936 crossref_primary_10_1016_j_vhri_2020_10_002 crossref_primary_10_1007_s15006_019_0783_2 crossref_primary_10_1038_s41388_019_0904_5 crossref_primary_10_1155_2019_5483791 crossref_primary_10_1186_s12943_016_0559_6 crossref_primary_10_1155_2020_9752952 crossref_primary_10_1016_j_tranon_2024_101976 crossref_primary_10_1007_s13193_023_01822_9 crossref_primary_10_1111_febs_13543 crossref_primary_10_1038_s41598_019_39629_w crossref_primary_10_1016_j_tele_2017_03_007 crossref_primary_10_2217_cer_2018_0142 crossref_primary_10_3390_jcm11195856 crossref_primary_10_3389_fmolb_2020_00118 crossref_primary_10_1016_j_soncn_2015_02_005 crossref_primary_10_1007_s10585_016_9796_8 crossref_primary_10_1097_GOX_0000000000002060 crossref_primary_10_3389_fonc_2014_00284 crossref_primary_10_1155_2018_3570526 crossref_primary_10_1002_advs_201901866 crossref_primary_10_1007_s40995_024_01660_6 crossref_primary_10_3892_ijmm_2015_2351 crossref_primary_10_3390_ijms232112875 crossref_primary_10_5888_pcd12_140491 crossref_primary_10_1007_s10549_017_4491_2 crossref_primary_10_1007_s11764_017_0646_8 crossref_primary_10_1016_j_biopha_2021_111899 crossref_primary_10_1093_oncolo_oyaf103 crossref_primary_10_1002_adfm_201801000 crossref_primary_10_1007_s10815_020_02030_y crossref_primary_10_1080_17425255_2017_1234605 crossref_primary_10_1016_j_biomaterials_2017_05_022 crossref_primary_10_1111_jcmm_15487 crossref_primary_10_1245_s10434_024_16482_4 crossref_primary_10_1080_07391102_2023_2198032 crossref_primary_10_1097_CM9_0000000000001152 crossref_primary_10_5812_aapm_103141 crossref_primary_10_3390_bios13030317 crossref_primary_10_1007_s00432_020_03184_z crossref_primary_10_1002_dc_23206 crossref_primary_10_1002_dc_23448 crossref_primary_10_1016_j_tranon_2016_05_001 crossref_primary_10_7759_cureus_12438 crossref_primary_10_1245_s10434_020_08945_1 crossref_primary_10_1038_s41419_018_1071_2 crossref_primary_10_1016_j_bbadis_2021_166300 crossref_primary_10_3389_fphar_2023_1052301 crossref_primary_10_1186_1471_2407_14_864 crossref_primary_10_1007_s10549_017_4166_z crossref_primary_10_1002_adfm_201504780 crossref_primary_10_1089_jayao_2020_0037 crossref_primary_10_1186_1472_6874_14_110 crossref_primary_10_1007_s40801_021_00278_z crossref_primary_10_3389_fonc_2020_587671 crossref_primary_10_1016_j_snb_2021_131304 crossref_primary_10_3389_fbioe_2018_00134 crossref_primary_10_1007_s10549_017_4449_4 crossref_primary_10_3390_gels6010010 crossref_primary_10_1038_s41598_017_12949_5 crossref_primary_10_1016_j_jss_2015_03_026 crossref_primary_10_1186_s12889_025_22092_w crossref_primary_10_1186_s12958_018_0443_x crossref_primary_10_1080_21655979_2021_1993715 crossref_primary_10_1016_j_beproc_2017_08_008 crossref_primary_10_1038_cddis_2015_116 crossref_primary_10_1016_j_abb_2014_09_002 crossref_primary_10_2174_1570180819666220330161006 crossref_primary_10_3389_fonc_2021_661184 crossref_primary_10_1097_AJP_0000000000000985 crossref_primary_10_4137_CMWH_S34698 crossref_primary_10_1038_s41467_019_13852_5 crossref_primary_10_1371_journal_pone_0104459 crossref_primary_10_1159_000371746 crossref_primary_10_1038_s41467_018_03411_9 crossref_primary_10_1111_tbj_12357 crossref_primary_10_1007_s12282_020_01179_9 crossref_primary_10_1080_21655979_2021_2009410 crossref_primary_10_1111_tbj_12350 crossref_primary_10_1016_j_gene_2019_144104 crossref_primary_10_3892_ol_2016_5044 crossref_primary_10_1002_mgg3_1598 crossref_primary_10_1016_j_bbcan_2017_10_003 crossref_primary_10_1016_j_tranon_2021_101096 crossref_primary_10_3390_ijerph17207692 crossref_primary_10_1245_s10434_018_6622_3 crossref_primary_10_1016_j_ejso_2016_07_006 crossref_primary_10_1093_toxsci_kfz213 crossref_primary_10_2217_bmt_15_1 crossref_primary_10_3390_antiox7100135 crossref_primary_10_1186_s12935_018_0592_1 crossref_primary_10_1016_j_omto_2021_03_007 crossref_primary_10_1080_09168451_2019_1588097 crossref_primary_10_1186_s12943_018_0933_7 crossref_primary_10_1016_j_ctrv_2017_08_005 crossref_primary_10_1007_s10552_017_0865_3 crossref_primary_10_1016_j_colsurfb_2019_04_061 crossref_primary_10_1590_1806_9282_63_04_371 crossref_primary_10_3390_app11136136 crossref_primary_10_1038_am_2015_83 crossref_primary_10_1111_jphp_13204 crossref_primary_10_1016_j_bioorg_2016_04_003 crossref_primary_10_1042_BSR20181223 crossref_primary_10_3390_cells9051280 crossref_primary_10_1002_cncr_29329 crossref_primary_10_1056_NEJMe1405746 crossref_primary_10_1007_s00438_018_1488_4 crossref_primary_10_1007_s12272_017_0923_0 crossref_primary_10_3233_CBM_170666 crossref_primary_10_1111_phn_12162 crossref_primary_10_3390_molecules28135149 crossref_primary_10_1007_s10549_018_4757_3 crossref_primary_10_1093_jncics_pky020 crossref_primary_10_1002_pds_5329 crossref_primary_10_1093_hropen_hoaa061 crossref_primary_10_5888_pcd13_160185 crossref_primary_10_1039_D1QM00464F crossref_primary_10_1080_24735132_2021_1980269 crossref_primary_10_1200_JCO_2014_57_2461 crossref_primary_10_1016_j_jep_2020_113363 crossref_primary_10_1038_s41401_020_00543_x crossref_primary_10_3727_096504016X14732514133203 crossref_primary_10_1073_pnas_1809681115 crossref_primary_10_1016_j_jmir_2019_02_003 crossref_primary_10_1038_cddis_2014_504 crossref_primary_10_1186_s12885_018_4607_z crossref_primary_10_1007_s00404_022_06440_4 crossref_primary_10_3390_molecules24213949 crossref_primary_10_1016_j_ejmech_2015_06_006 crossref_primary_10_1158_0008_5472_CAN_20_0922 crossref_primary_10_3892_or_2017_5644 crossref_primary_10_1016_j_ejca_2015_05_007 crossref_primary_10_1097_MD_0000000000004547 crossref_primary_10_1186_s12885_016_2626_1 crossref_primary_10_1038_ijo_2015_205 crossref_primary_10_3389_fonc_2014_00274 crossref_primary_10_1007_s12553_022_00707_1 crossref_primary_10_1109_ACCESS_2019_2898121 crossref_primary_10_1016_j_ijpharm_2019_03_006 crossref_primary_10_1016_j_ultrasmedbio_2017_09_012 crossref_primary_10_1097_ALN_0000000000001173 crossref_primary_10_3109_10717544_2015_1049721 crossref_primary_10_7759_cureus_47763 crossref_primary_10_1186_s12885_019_5580_x crossref_primary_10_1016_j_ejso_2020_11_130 crossref_primary_10_3390_cancers6020741 crossref_primary_10_1007_s10903_018_0772_z crossref_primary_10_2217_fon_2019_0017 crossref_primary_10_1007_s10549_016_3734_y crossref_primary_10_3390_diseases4020017 crossref_primary_10_1158_0008_5472_CAN_15_3091 crossref_primary_10_1002_jso_24579 crossref_primary_10_1016_j_tranon_2019_02_014 crossref_primary_10_3892_etm_2017_4648 crossref_primary_10_3892_ol_2017_5612 crossref_primary_10_1111_jcmm_14171 crossref_primary_10_3892_ol_2018_9077 crossref_primary_10_1016_j_bbrc_2018_04_119 crossref_primary_10_1111_tbj_13005 crossref_primary_10_1038_s41598_021_88494_z crossref_primary_10_1128_MCB_00076_14 crossref_primary_10_1186_s40164_016_0058_x crossref_primary_10_1245_s10434_019_07741_w crossref_primary_10_3390_molecules21010120 crossref_primary_10_1007_s10549_017_4627_4 crossref_primary_10_1007_s10689_017_0036_4 crossref_primary_10_1186_s12955_016_0428_4 crossref_primary_10_1016_j_semcancer_2019_12_022 crossref_primary_10_1016_j_breast_2015_07_006 crossref_primary_10_1016_j_canlet_2025_217457 crossref_primary_10_1002_cnr2_1353 crossref_primary_10_1016_j_jnutbio_2016_11_005 crossref_primary_10_3109_13697137_2014_929105 crossref_primary_10_1002_cbin_10890 crossref_primary_10_1111_tbj_12545 crossref_primary_10_1038_s41420_021_00426_y crossref_primary_10_1186_s12951_021_00891_8 crossref_primary_10_3892_ijo_2019_4920 crossref_primary_10_1016_j_canep_2018_10_015 crossref_primary_10_1186_s12871_019_0700_3 crossref_primary_10_1016_j_socscimed_2018_03_016 crossref_primary_10_1039_C4TX00098F crossref_primary_10_3390_ijms151120706 crossref_primary_10_1038_ncomms6086 crossref_primary_10_3390_jpm5030280 crossref_primary_10_34172_bi_2022_23682 crossref_primary_10_1136_bmjopen_2018_028461 crossref_primary_10_3892_ol_2017_6292 crossref_primary_10_4103_0973_1482_160917 crossref_primary_10_1016_j_biopha_2016_10_050 crossref_primary_10_1016_j_pmr_2016_09_003 crossref_primary_10_1007_s10549_016_3691_5 crossref_primary_10_1002_wsbm_1343 crossref_primary_10_1007_s10552_016_0746_1 crossref_primary_10_1089_cmb_2019_0131 crossref_primary_10_3892_ijo_2015_3253 crossref_primary_10_1016_j_ctrv_2015_04_009 crossref_primary_10_1089_cmb_2017_0010 crossref_primary_10_3390_nano8110953 crossref_primary_10_1002_ijc_29801 crossref_primary_10_3389_fnhum_2015_00465 crossref_primary_10_1097_JWH_0000000000000060 crossref_primary_10_3390_nu9070728 crossref_primary_10_1016_j_jtha_2022_12_001 crossref_primary_10_1016_j_surg_2015_03_056 crossref_primary_10_3389_fonc_2024_1332148 crossref_primary_10_1016_j_biopha_2014_09_011 crossref_primary_10_3390_ncrna9010001 crossref_primary_10_1002_mp_14832 crossref_primary_10_1111_cbdd_12521 crossref_primary_10_1186_s12885_020_07609_3 crossref_primary_10_1016_j_healthplace_2020_102333 crossref_primary_10_1186_s12885_015_1394_7 crossref_primary_10_1186_s13058_014_0465_z crossref_primary_10_1590_1806_9282_63_07_566 crossref_primary_10_1016_j_mgene_2017_07_004 crossref_primary_10_3389_fonc_2022_865067 crossref_primary_10_1097_AAP_0000000000000163 crossref_primary_10_1016_j_pdpdt_2016_04_001 crossref_primary_10_1200_JGO_17_00135 crossref_primary_10_3389_fimmu_2022_927565 crossref_primary_10_1111_biom_13208 crossref_primary_10_3892_mco_2016_827 crossref_primary_10_1055_s_0037_1604181 crossref_primary_10_1111_tbj_12758 crossref_primary_10_1007_s10549_015_3611_0 crossref_primary_10_1016_j_ultrasmedbio_2015_02_014 crossref_primary_10_1002_mp_13966 crossref_primary_10_3892_or_2016_4647 crossref_primary_10_3892_ol_2017_7158 crossref_primary_10_2147_BCTT_S366530 crossref_primary_10_1007_s10552_020_01292_2 crossref_primary_10_1038_s41467_020_17680_w crossref_primary_10_1016_j_jconrel_2024_11_026 crossref_primary_10_3389_fonc_2021_619817 crossref_primary_10_1007_s10549_015_3283_9 crossref_primary_10_1038_s41598_017_08240_2 crossref_primary_10_2217_WHE_15_2 crossref_primary_10_1007_s11033_018_4394_2 crossref_primary_10_1371_journal_pone_0122209 crossref_primary_10_1007_s00520_014_2554_z crossref_primary_10_1186_s12935_024_03525_9 crossref_primary_10_1245_s10434_015_4586_0 crossref_primary_10_1016_j_yexcr_2018_05_014 crossref_primary_10_1111_jcpt_13500 crossref_primary_10_1007_s10549_015_3528_7 crossref_primary_10_1038_s41431_019_0424_3 crossref_primary_10_1038_s41598_019_42144_7 crossref_primary_10_2217_bmt_14_41 crossref_primary_10_1111_cas_15090 crossref_primary_10_2196_publichealth_8163 crossref_primary_10_1002_jcla_23369 crossref_primary_10_1016_j_biopha_2017_06_021 crossref_primary_10_1002_mc_22295 crossref_primary_10_1007_s10549_015_3317_3 crossref_primary_10_1021_acs_jmedchem_7b01407 crossref_primary_10_1007_s11030_017_9731_1 crossref_primary_10_1097_SAP_0000000000002642 crossref_primary_10_1186_s12885_016_2766_3 crossref_primary_10_1016_j_omto_2021_05_006 crossref_primary_10_1016_j_bbcan_2018_04_006 crossref_primary_10_1186_s12885_020_06919_w crossref_primary_10_3892_ol_2018_7991 crossref_primary_10_1016_j_jclinane_2018_10_040 crossref_primary_10_1097_CAD_0000000000000498 crossref_primary_10_1155_2017_6950579 crossref_primary_10_1038_modpathol_2017_74 crossref_primary_10_1007_s10549_017_4207_7 crossref_primary_10_1016_j_biopha_2019_109006 crossref_primary_10_1016_j_gene_2018_01_100 crossref_primary_10_2217_bmt_14_52 crossref_primary_10_1002_jcp_29517 crossref_primary_10_3892_etm_2019_7601 crossref_primary_10_1007_s10549_020_05777_1 crossref_primary_10_1177_0272684X19885501 crossref_primary_10_3892_etm_2016_3630 crossref_primary_10_1016_j_sapharm_2014_12_002 crossref_primary_10_1155_2016_5436458 crossref_primary_10_3389_fonc_2022_854137 crossref_primary_10_1039_C8TB00319J crossref_primary_10_1177_1524839918782168 crossref_primary_10_1155_2019_5072506 crossref_primary_10_1080_01635581_2015_1002625 crossref_primary_10_1188_17_ONF_66_76 crossref_primary_10_1111_acps_12459 crossref_primary_10_3389_fcell_2016_00093 crossref_primary_10_1016_j_ijrobp_2014_06_042 crossref_primary_10_1089_cbr_2019_3389 crossref_primary_10_26810_perioj_2020_a3 crossref_primary_10_1186_s40659_018_0189_0 crossref_primary_10_1002_cam4_1603 crossref_primary_10_1007_s00520_019_04698_0 crossref_primary_10_1139_bcb_2018_0168 crossref_primary_10_1007_s13238_014_0088_2 crossref_primary_10_1016_j_jsbmb_2014_09_015 crossref_primary_10_1111_jcmm_13922 crossref_primary_10_1177_10732748221089412 crossref_primary_10_1186_s12885_017_3359_5 crossref_primary_10_3233_THC_202226 crossref_primary_10_1002_cncr_29371 crossref_primary_10_1007_s10549_014_3195_0 crossref_primary_10_1186_s13256_016_1180_4 crossref_primary_10_1016_j_prp_2019_152592 crossref_primary_10_4103_ijc_IJC_458_18 crossref_primary_10_1016_j_omtn_2018_07_014 crossref_primary_10_1634_theoncologist_2016_0033 crossref_primary_10_2478_pjst_2019_0017 crossref_primary_10_1016_j_clbc_2016_11_001 crossref_primary_10_1016_j_ejon_2024_102678 crossref_primary_10_1038_s41598_025_94084_0 crossref_primary_10_1093_jtm_taw055 crossref_primary_10_7717_peerj_2542 crossref_primary_10_3389_fphar_2022_979634 crossref_primary_10_1371_journal_pone_0112720 crossref_primary_10_3390_ijerph13010046 crossref_primary_10_1007_s10863_018_9750_3 crossref_primary_10_1097_MD_0000000000024751 crossref_primary_10_3389_fgene_2014_00149 crossref_primary_10_3390_biology10020116 crossref_primary_10_1038_s41389_018_0113_z crossref_primary_10_1080_0284186X_2018_1548775 crossref_primary_10_1097_MD_0000000000037826 crossref_primary_10_1245_s10434_018_6859_x crossref_primary_10_1016_j_ejmech_2014_08_050 crossref_primary_10_1038_s41598_018_23833_1 crossref_primary_10_1111_tbj_12703 crossref_primary_10_1136_bmjopen_2021_054135 crossref_primary_10_1515_med_2020_0223 crossref_primary_10_1002_pbc_27397 crossref_primary_10_1186_s13058_016_0736_y crossref_primary_10_1371_journal_pone_0192888 crossref_primary_10_3390_ijms19051375 crossref_primary_10_1016_j_ijmedinf_2017_02_012 crossref_primary_10_7717_peerj_8183 crossref_primary_10_1093_jnci_dju210 crossref_primary_10_1080_10408398_2020_1855413 crossref_primary_10_1049_iet_cvi_2016_0425 crossref_primary_10_1155_2017_2059036 crossref_primary_10_3389_fonc_2022_999894 crossref_primary_10_3892_ijo_2018_4387 crossref_primary_10_1016_j_tox_2016_09_006 crossref_primary_10_1111_1759_7714_12575 crossref_primary_10_3892_ijo_2016_3825 crossref_primary_10_1080_08982104_2017_1370471 crossref_primary_10_3390_jpm12020133 crossref_primary_10_1002_jcp_27196 crossref_primary_10_1016_j_cellsig_2020_109697 crossref_primary_10_1123_jpah_2019_0037 crossref_primary_10_1016_j_genrep_2020_100753 crossref_primary_10_1093_jnci_djv318 crossref_primary_10_3892_ol_2017_6462 crossref_primary_10_1002_iub_1749 crossref_primary_10_3390_md13063950 crossref_primary_10_1007_s00280_019_03981_5 crossref_primary_10_3389_fbioe_2021_600579 crossref_primary_10_1016_j_yjbinx_2018_100001 crossref_primary_10_12677_WJCR_2022_123016 crossref_primary_10_3892_mmr_2018_9789 crossref_primary_10_3390_mti1040029 crossref_primary_10_1016_j_biopha_2018_10_107 crossref_primary_10_1186_s12885_019_5589_1 crossref_primary_10_1016_j_abb_2018_05_018 crossref_primary_10_1080_08870446_2021_1941960 crossref_primary_10_1007_s10549_017_4259_8 crossref_primary_10_1016_j_jtcvs_2015_08_092 crossref_primary_10_3389_fonc_2020_00621 crossref_primary_10_1371_journal_pone_0097697 crossref_primary_10_1080_15384101_2020_1839700 crossref_primary_10_4103_0973_1482_167611 crossref_primary_10_1371_journal_pone_0235662 crossref_primary_10_3892_ol_2015_3960 crossref_primary_10_1242_dev_200162 crossref_primary_10_1016_j_canlet_2018_05_018 crossref_primary_10_1007_s13277_015_3293_6 crossref_primary_10_2174_1573406415666190621094704 crossref_primary_10_1080_09581596_2015_1117576 crossref_primary_10_3389_fbioe_2019_00226 crossref_primary_10_3892_ol_2018_9552 crossref_primary_10_1016_j_abst_2022_01_001 crossref_primary_10_1093_aje_kwv448 crossref_primary_10_1517_17425255_2015_1078311 crossref_primary_10_1186_s12885_021_08112_z crossref_primary_10_1016_j_pec_2017_06_032 crossref_primary_10_1080_14737159_2022_2167556 crossref_primary_10_1177_1178223420931511 crossref_primary_10_1016_j_gene_2018_11_075 crossref_primary_10_3892_or_2015_4311 crossref_primary_10_1007_s13304_017_0424_1 crossref_primary_10_3402_jchimp_v5_28935 crossref_primary_10_1177_1534735418766416 crossref_primary_10_1093_aje_kwv226 crossref_primary_10_1038_srep07139 crossref_primary_10_1016_j_yexcr_2014_05_017 crossref_primary_10_4103_nmj_NMJ_112_17 crossref_primary_10_1007_s11030_023_10621_x crossref_primary_10_3748_wjg_v20_i32_11142 crossref_primary_10_1016_j_eurger_2015_11_003 crossref_primary_10_1007_s10549_018_4750_x crossref_primary_10_1089_jwh_2014_1511 crossref_primary_10_7759_cureus_32513 crossref_primary_10_1186_s12885_025_14172_2 crossref_primary_10_2174_0115733947288059240405041146 crossref_primary_10_1002_ijc_29434 crossref_primary_10_1080_24701556_2021_2025085 crossref_primary_10_1002_aoc_5269 crossref_primary_10_1007_s13577_022_00752_y crossref_primary_10_1177_107327481602300210 crossref_primary_10_1371_journal_pone_0145615 crossref_primary_10_1097_COC_0000000000000962 crossref_primary_10_1089_dna_2016_3282 crossref_primary_10_1080_13813455_2020_1754430 crossref_primary_10_1186_s12885_016_2204_6 crossref_primary_10_1088_1742_6596_1853_1_012061 crossref_primary_10_1007_s13277_014_2799_7 crossref_primary_10_1016_j_wneu_2015_07_068 crossref_primary_10_1259_bjr_20150802 crossref_primary_10_1016_j_canlet_2015_07_046 crossref_primary_10_1007_s10549_015_3486_0 crossref_primary_10_1016_j_canlet_2015_07_045 crossref_primary_10_3892_mmr_2015_3757 crossref_primary_10_1080_21655979_2021_1951929 crossref_primary_10_1016_j_semcancer_2019_07_011 crossref_primary_10_1007_s00737_015_0504_5 crossref_primary_10_1142_S2196888824500210 crossref_primary_10_7314_APJCP_2015_16_7_2857 crossref_primary_10_1126_scitranslmed_3010277 crossref_primary_10_3892_ol_2016_5529 crossref_primary_10_1016_j_ebiom_2016_08_014 crossref_primary_10_1097_MD_0000000000011898 crossref_primary_10_5005_jp_journals_10049_2064 crossref_primary_10_1016_j_biopha_2017_01_062 crossref_primary_10_31083_JFSFQ39341 crossref_primary_10_1016_j_ejso_2017_05_012 crossref_primary_10_3892_ol_2019_10038 crossref_primary_10_1007_s10552_016_0736_3 crossref_primary_10_1016_j_cca_2015_09_028 crossref_primary_10_1200_JGO_19_00263 crossref_primary_10_1073_pnas_1414358111 crossref_primary_10_1007_s10549_015_3584_z crossref_primary_10_3892_br_2015_536 crossref_primary_10_1155_2023_2875972 crossref_primary_10_1007_s13562_017_0407_9 crossref_primary_10_1007_s10815_022_02477_1 crossref_primary_10_1016_j_vhri_2015_03_020 crossref_primary_10_1111_jcmm_12673 crossref_primary_10_1371_journal_pone_0122734 crossref_primary_10_1186_s13046_017_0640_z crossref_primary_10_4102_sajo_v8i0_286 crossref_primary_10_1016_j_biopha_2017_01_072 crossref_primary_10_3892_ijo_2016_3400 crossref_primary_10_1371_journal_pone_0142574 crossref_primary_10_1111_cpr_12266 crossref_primary_10_3390_ijms18010142 crossref_primary_10_3390_ijms23010262 crossref_primary_10_3892_ijo_2016_3406 crossref_primary_10_1186_s12885_015_1018_2 crossref_primary_10_1186_s12955_019_1224_8 crossref_primary_10_3390_ijms22010173 crossref_primary_10_1186_s12885_015_1410_y crossref_primary_10_3389_fonc_2022_819756 crossref_primary_10_3389_fphys_2022_977189 crossref_primary_10_3390_md13041785 crossref_primary_10_1038_s41598_019_50084_5 crossref_primary_10_1038_s41419_018_1220_7 crossref_primary_10_1038_s41598_018_24539_0 crossref_primary_10_1016_j_gene_2019_100014 crossref_primary_10_1186_s40349_017_0101_3 crossref_primary_10_3892_mmr_2018_9721 crossref_primary_10_1016_j_bmc_2018_11_014 crossref_primary_10_1016_j_jmir_2021_12_002 crossref_primary_10_1080_21691401_2019_1638791 crossref_primary_10_1007_s10549_016_3906_9 crossref_primary_10_3892_ol_2018_9160 crossref_primary_10_1155_2022_7812218 crossref_primary_10_3892_etm_2019_8207 crossref_primary_10_1371_journal_pone_0128472 crossref_primary_10_1007_s10552_019_01168_0 crossref_primary_10_1097_MD_0000000000035493 crossref_primary_10_1093_carcin_bgu155 crossref_primary_10_1186_s12916_022_02260_0 crossref_primary_10_4137_CMO_S22456 crossref_primary_10_1002_mgg3_528 crossref_primary_10_1186_s12885_016_2324_z crossref_primary_10_1016_j_abb_2015_09_006 crossref_primary_10_1016_j_semcancer_2019_07_006 crossref_primary_10_5812_ircmj_31277 crossref_primary_10_1155_2015_539721 crossref_primary_10_1002_jso_23825 crossref_primary_10_1016_j_radonc_2017_08_004 crossref_primary_10_2147_IJGM_S314055 crossref_primary_10_18632_oncotarget_15351 crossref_primary_10_1007_s00262_020_02511_0 crossref_primary_10_1007_s12672_019_00373_2 crossref_primary_10_1053_j_ro_2014_04_011 crossref_primary_10_1016_j_bioactmat_2021_10_007 crossref_primary_10_4103_abr_abr_221_21 crossref_primary_10_1016_j_phrs_2019_104452 crossref_primary_10_1007_s10147_021_02098_1 crossref_primary_10_1007_s10549_014_3158_5 crossref_primary_10_1111_jocn_15114 crossref_primary_10_1186_s12951_017_0311_4 crossref_primary_10_4081_acbr_2023_343 crossref_primary_10_1245_s10434_014_4313_2 crossref_primary_10_1016_j_hermed_2021_100449 crossref_primary_10_1016_j_prp_2018_07_030 crossref_primary_10_3892_ol_2017_7702 crossref_primary_10_1186_1742_4755_11_50 crossref_primary_10_1155_2023_6435776 crossref_primary_10_1007_s00604_023_05694_2 crossref_primary_10_1007_s10549_015_3499_8 crossref_primary_10_1007_s12282_019_00976_1 crossref_primary_10_3892_mmr_2017_7717 crossref_primary_10_1002_cncr_34015 crossref_primary_10_3389_fonc_2023_1240098 crossref_primary_10_1080_08982104_2023_2248505 crossref_primary_10_1002_kjm2_12075 crossref_primary_10_1097_MD_0000000000004515 crossref_primary_10_1016_j_mcp_2019_06_005 crossref_primary_10_1186_s40001_023_01329_7 crossref_primary_10_3109_07357907_2015_1118113 crossref_primary_10_1016_j_dnarep_2021_103214 crossref_primary_10_1371_journal_pone_0133830 crossref_primary_10_1016_j_humimm_2021_02_001 crossref_primary_10_3892_ijo_2015_2932 crossref_primary_10_3348_kjr_2014_15_5_578 crossref_primary_10_1089_cbr_2019_2925 crossref_primary_10_1186_s12905_015_0171_8 crossref_primary_10_1007_s12602_021_09756_w crossref_primary_10_1002_ddr_21860 crossref_primary_10_1007_s12032_017_0998_y crossref_primary_10_1002_jcb_25229 crossref_primary_10_1002_jcb_26559 crossref_primary_10_3892_or_2015_3857 crossref_primary_10_1007_s00228_018_2505_6 crossref_primary_10_12677_WJCR_2019_93012 crossref_primary_10_1002_jbm_a_36205 crossref_primary_10_1097_MD_0000000000026970 crossref_primary_10_1007_s11912_021_01049_3 crossref_primary_10_1016_j_canlet_2019_01_005 crossref_primary_10_2217_ije_15_31 crossref_primary_10_3390_bios10100149 crossref_primary_10_1186_s12967_021_03021_y crossref_primary_10_1891_2380_9418_10_1_38 crossref_primary_10_1093_her_cyx033 crossref_primary_10_1186_s13058_019_1236_7 crossref_primary_10_3892_mmr_2019_10367 crossref_primary_10_1002_cam4_3432 crossref_primary_10_1016_j_yexmp_2015_08_021 crossref_primary_10_1002_jcb_29633 crossref_primary_10_1038_s41419_022_04777_x crossref_primary_10_7314_APJCP_2015_16_6_2385 crossref_primary_10_2217_nnm_2018_0004 crossref_primary_10_1016_j_imu_2022_100894 crossref_primary_10_1186_s13046_019_1096_0 crossref_primary_10_1038_s41598_018_38214_x crossref_primary_10_1007_s13670_017_0223_z crossref_primary_10_1016_j_cpet_2014_12_004 crossref_primary_10_1016_j_annepidem_2015_09_003 crossref_primary_10_3389_fgene_2022_869906 crossref_primary_10_1186_s13058_019_1201_5 crossref_primary_10_1097_MD_0000000000002771 crossref_primary_10_1007_s13277_015_3266_9 crossref_primary_10_5582_bst_2016_01091 crossref_primary_10_1038_s41467_018_05852_8 crossref_primary_10_3892_mmr_2019_10112 crossref_primary_10_1007_s00138_019_01020_0 crossref_primary_10_3390_nu11112656 crossref_primary_10_1371_journal_pone_0140329 crossref_primary_10_18282_po3689 crossref_primary_10_1080_07357907_2019_1695816 crossref_primary_10_1080_21655979_2022_2115616 crossref_primary_10_1158_0008_5472_CAN_17_1721 crossref_primary_10_3892_mmr_2017_6816 crossref_primary_10_2217_epi_14_28 crossref_primary_10_4103_ija_IJA_639_19 crossref_primary_10_1016_j_biopha_2014_12_002 crossref_primary_10_3892_etm_2019_8017 crossref_primary_10_1002_jmri_25798 crossref_primary_10_1007_s42979_023_01879_x crossref_primary_10_1007_s10549_016_3994_6 crossref_primary_10_3389_fonc_2020_01519 crossref_primary_10_1177_1533033819875168 crossref_primary_10_1007_s10549_019_05356_z crossref_primary_10_1186_1471_2407_14_781 crossref_primary_10_1155_2015_209458 crossref_primary_10_1016_j_critrevonc_2017_03_016 crossref_primary_10_1007_s10585_014_9667_0 crossref_primary_10_1200_EDBK_159069 crossref_primary_10_1038_bmt_2015_63 crossref_primary_10_1007_s00604_017_2481_z crossref_primary_10_1002_jcb_28769 crossref_primary_10_1016_j_fob_2015_05_003 crossref_primary_10_1186_s12935_020_01659_0 crossref_primary_10_1093_g3journal_jkac288 crossref_primary_10_1007_s00018_023_04688_w crossref_primary_10_3233_JIFS_219250 crossref_primary_10_1016_j_bbrc_2017_09_005 crossref_primary_10_1080_15598608_2016_1152205 crossref_primary_10_1016_j_biopha_2017_03_069 crossref_primary_10_3892_ol_2019_10683 crossref_primary_10_1002_adhm_201700550 crossref_primary_10_1002_mabi_201600340 crossref_primary_10_1007_s11916_017_0637_5 crossref_primary_10_1038_srep24502 crossref_primary_10_3892_ijo_2015_2973 crossref_primary_10_1007_s12032_014_0375_z crossref_primary_10_1039_C9RA08970E crossref_primary_10_1111_jpi_12467 crossref_primary_10_3892_mmr_2018_9763 crossref_primary_10_1016_j_apt_2020_07_025 crossref_primary_10_1007_s11482_018_9622_3 crossref_primary_10_1007_s40336_021_00456_7 crossref_primary_10_3390_cells10020215 crossref_primary_10_3390_molecules23061420 crossref_primary_10_1038_srep21242 crossref_primary_10_3390_cells11233818 crossref_primary_10_1177_1099800414568100 crossref_primary_10_3892_ijo_2014_2715 crossref_primary_10_1016_j_jnutbio_2021_108763 crossref_primary_10_1080_09638288_2018_1514663 crossref_primary_10_1002_cam4_1576 crossref_primary_10_1155_2021_2649123 crossref_primary_10_4103_jcrt_JCRT_582_17 crossref_primary_10_1002_jcla_22193 crossref_primary_10_1155_2022_1922263 crossref_primary_10_1016_j_clbc_2018_05_005 crossref_primary_10_1097_CAD_0000000000000184 crossref_primary_10_1016_S1875_5364_17_30012_2 crossref_primary_10_1016_j_jcpo_2019_100214 crossref_primary_10_1089_jwh_2017_6863 crossref_primary_10_1016_j_jdcr_2016_06_006 crossref_primary_10_1097_CEJ_0000000000000667 crossref_primary_10_1186_s12885_020_07158_9 crossref_primary_10_1016_j_bios_2016_08_028 crossref_primary_10_3390_cancers12020355 crossref_primary_10_3892_ol_2018_8917 crossref_primary_10_1002_jcp_26332 crossref_primary_10_1177_1534735420918945 crossref_primary_10_1186_s12967_019_02173_2 crossref_primary_10_1016_j_apsusc_2015_01_204 crossref_primary_10_1007_s13277_014_2509_5 crossref_primary_10_1038_srep16553 crossref_primary_10_1016_j_phrs_2016_06_007 crossref_primary_10_1080_07391102_2023_2252091 crossref_primary_10_1038_bjc_2016_98 crossref_primary_10_1007_s13277_015_4286_1 crossref_primary_10_1016_j_biomaterials_2019_01_007 crossref_primary_10_1038_s41419_017_0094_4 crossref_primary_10_1002_open_201900037 crossref_primary_10_1038_s41598_020_64564_6 crossref_primary_10_1155_2015_854307 crossref_primary_10_1016_j_jnci_2015_04_002 crossref_primary_10_1016_j_pdpdt_2025_104579 crossref_primary_10_1016_j_biopha_2023_114362 crossref_primary_10_1080_10715762_2017_1295452 crossref_primary_10_1007_s00530_021_00823_4 crossref_primary_10_1016_j_ijsu_2017_06_049 crossref_primary_10_1007_s10549_018_4810_2 crossref_primary_10_1177_0300060521999568 crossref_primary_10_1515_pterid_2016_0005 crossref_primary_10_1186_s12885_019_6260_6 crossref_primary_10_1097_RCT_0000000000000647 crossref_primary_10_3389_fimmu_2018_01765 crossref_primary_10_1007_s12529_016_9577_4 crossref_primary_10_1097_MD_0000000000036049 crossref_primary_10_1016_j_jss_2016_05_031 crossref_primary_10_3727_096504018X15213126075068 crossref_primary_10_1002_elan_202060039 crossref_primary_10_1002_smll_201601829 crossref_primary_10_1038_s41598_019_42776_9 crossref_primary_10_1016_j_aca_2018_08_009 crossref_primary_10_1002_jmri_26556 crossref_primary_10_1109_JBHI_2019_2960821 crossref_primary_10_1016_j_radonc_2018_01_007 crossref_primary_10_1177_1474515118755729 crossref_primary_10_2217_fon_14_55 crossref_primary_10_1002_cnr2_70187 crossref_primary_10_3390_jcm10122610 crossref_primary_10_3892_mmr_2015_4393 crossref_primary_10_1016_j_biopha_2018_09_096 crossref_primary_10_1177_1010428317711571 crossref_primary_10_1007_s00428_017_2189_9 crossref_primary_10_1016_j_xphs_2016_06_021 crossref_primary_10_3390_ijms19092552 crossref_primary_10_1007_s00438_014_0983_5 crossref_primary_10_1016_j_ejmech_2017_11_065 crossref_primary_10_1002_mc_22318 crossref_primary_10_1007_s13193_016_0512_6 crossref_primary_10_1097_NMD_0000000000000904 crossref_primary_10_1007_s10549_020_05541_5 crossref_primary_10_4161_15384101_2014_956507 crossref_primary_10_1080_2162402X_2021_2004659 crossref_primary_10_3892_mmr_2016_5293 crossref_primary_10_1080_14756366_2019_1609469 crossref_primary_10_1089_jwh_2017_6425 crossref_primary_10_1016_j_clbc_2018_06_006 crossref_primary_10_1371_journal_pone_0139846 crossref_primary_10_2147_CMAR_S244606 crossref_primary_10_1016_j_gim_2021_11_008 crossref_primary_10_1186_s12943_019_1124_x crossref_primary_10_18027_2224_5057_2018_8_3_68_77 crossref_primary_10_1080_22423982_2019_1633190 crossref_primary_10_1016_j_bbrc_2014_06_134 crossref_primary_10_1007_s00432_014_1726_z crossref_primary_10_1111_ecc_13082 crossref_primary_10_3390_polym10060581 crossref_primary_10_2196_40386 crossref_primary_10_1177_0962280220962516 crossref_primary_10_1186_s12885_021_07789_6 crossref_primary_10_1016_j_bcp_2018_03_022 crossref_primary_10_1111_bcpt_13042 crossref_primary_10_1007_s11517_015_1280_0 crossref_primary_10_1186_s13000_017_0608_5 crossref_primary_10_1007_s00520_015_2758_x crossref_primary_10_1038_srep30207 crossref_primary_10_3390_nano8020067 crossref_primary_10_3892_ol_2019_10984 crossref_primary_10_1016_j_ejso_2015_05_007 crossref_primary_10_1016_j_biopha_2019_109764 crossref_primary_10_1111_cpr_12720 crossref_primary_10_1007_s12282_023_01472_3 crossref_primary_10_1016_j_chemolab_2015_06_011 crossref_primary_10_1016_j_jep_2025_120336 crossref_primary_10_1016_j_bbadis_2018_01_031 crossref_primary_10_2147_CMAR_S249041 crossref_primary_10_1007_s00520_019_04814_0 crossref_primary_10_1016_j_currproblcancer_2021_100723 crossref_primary_10_1007_s10900_019_00697_8 crossref_primary_10_1007_s11936_019_0738_z crossref_primary_10_1016_j_biopha_2018_01_155 crossref_primary_10_1053_j_sult_2022_10_002 crossref_primary_10_1093_carcin_bgu120 crossref_primary_10_3390_genes13091538 crossref_primary_10_4103_jmau_jmau_57_23 crossref_primary_10_1016_j_freeradbiomed_2014_11_012 crossref_primary_10_1080_17425247_2023_2273830 crossref_primary_10_1136_bcr_2016_219124 crossref_primary_10_1097_MD_0000000000006860 crossref_primary_10_1111_cas_13644 crossref_primary_10_3390_ijerph13050482 crossref_primary_10_1007_s10549_023_07058_z crossref_primary_10_1007_s12282_015_0638_3 crossref_primary_10_1016_j_addr_2016_08_011 crossref_primary_10_1016_j_ebiom_2019_05_036 crossref_primary_10_1007_s10109_020_00323_5 crossref_primary_10_1007_s10549_017_4363_9 crossref_primary_10_1038_s41598_020_76663_5 crossref_primary_10_1002_mc_22352 crossref_primary_10_1038_s41416_020_0821_y crossref_primary_10_1002_jum_14247 crossref_primary_10_5812_ijcm_8016 crossref_primary_10_1001_jamanetworkopen_2022_55697 crossref_primary_10_1097_JHQ_0000000000000046 crossref_primary_10_1007_s13277_015_4360_8 crossref_primary_10_1016_j_cclet_2018_10_004 crossref_primary_10_1038_srep12133 crossref_primary_10_15171_apb_2016_024 crossref_primary_10_1016_j_bbrc_2017_02_106 crossref_primary_10_1002_pon_5696 crossref_primary_10_1038_s41419_018_0669_8 crossref_primary_10_4103_ijc_IJC_97_21 crossref_primary_10_1002_advs_201802281 crossref_primary_10_2147_OTT_S241632 crossref_primary_10_1007_s11538_022_01054_y crossref_primary_10_3892_mmr_2018_9294 crossref_primary_10_1016_j_jelechem_2015_05_038 crossref_primary_10_3390_pharmaceutics14081544 crossref_primary_10_4081_mw_2025_25 crossref_primary_10_1097_SLA_0000000000001302 crossref_primary_10_1186_s12885_019_5902_z crossref_primary_10_1016_j_breast_2016_09_016 crossref_primary_10_1097_RCT_0000000000000226 crossref_primary_10_1111_tbj_13519 crossref_primary_10_1007_s12272_017_0979_x crossref_primary_10_1007_s40122_020_00234_9 crossref_primary_10_1093_jamia_ocw161 crossref_primary_10_3892_mco_2024_2758 crossref_primary_10_1016_j_actbio_2015_07_020 crossref_primary_10_1109_TBME_2020_3014277 crossref_primary_10_1007_s00520_016_3389_6 crossref_primary_10_1007_s00520_020_05722_4 crossref_primary_10_1007_s13277_015_4233_1 crossref_primary_10_2310_7290_2014_00010 crossref_primary_10_1093_jn_nxy187 crossref_primary_10_1038_s41598_022_17414_6 crossref_primary_10_1007_s11280_017_0522_5 crossref_primary_10_1245_s10434_014_4240_2 crossref_primary_10_1007_s11864_018_0547_8 crossref_primary_10_1007_s00266_016_0634_9 crossref_primary_10_1186_s12880_022_00875_6 crossref_primary_10_1007_s10552_015_0548_x crossref_primary_10_1186_s13167_015_0037_z crossref_primary_10_1016_j_biopha_2018_09_033 crossref_primary_10_1186_s12885_017_3876_2 crossref_primary_10_1016_j_bbrc_2015_11_071 crossref_primary_10_1002_2211_5463_12004 crossref_primary_10_1515_fon_2018_0021 crossref_primary_10_1007_s12282_021_01325_x crossref_primary_10_3389_fonc_2023_1148628 crossref_primary_10_1016_j_mce_2021_111181 crossref_primary_10_1159_000521097 crossref_primary_10_1038_s41598_019_42132_x crossref_primary_10_3389_fcell_2021_750897 crossref_primary_10_3892_ijo_2015_3114 crossref_primary_10_1038_s41467_021_23316_4 crossref_primary_10_1155_2025_5824491 crossref_primary_10_1007_s10897_016_9986_1 crossref_primary_10_1097_COC_0000000000000351 crossref_primary_10_3390_cancers17030544 crossref_primary_10_1016_j_heliyon_2024_e27529 crossref_primary_10_3892_mmr_2018_9273 crossref_primary_10_1007_s11033_016_3942_x crossref_primary_10_1136_bcr_2022_250108 crossref_primary_10_1074_jbc_M114_594721 crossref_primary_10_3892_ol_2017_7029 crossref_primary_10_1155_2019_6397513 crossref_primary_10_1007_s13577_015_0124_4 crossref_primary_10_5306_wjco_v5_i2_61 crossref_primary_10_1016_j_redare_2017_11_017 crossref_primary_10_3390_ijms23031672 crossref_primary_10_3390_cells9020427 crossref_primary_10_1038_cddiscovery_2017_39 crossref_primary_10_1177_03936155221086599 crossref_primary_10_12998_wjcc_v10_i12_3698 crossref_primary_10_3109_10837450_2015_1049706 crossref_primary_10_1016_j_bspc_2023_105450 crossref_primary_10_1634_theoncologist_2014_0036 crossref_primary_10_1111_cpr_12741 crossref_primary_10_1021_jacs_6b09538 crossref_primary_10_1007_s12282_018_0837_9 crossref_primary_10_1097_PAI_0000000000000151 crossref_primary_10_1148_rg_220165 crossref_primary_10_3390_biom9020040 crossref_primary_10_1016_j_jconrel_2016_01_053 crossref_primary_10_1111_jcmm_15185 crossref_primary_10_1016_j_molonc_2016_01_002 crossref_primary_10_1007_s13566_016_0252_9 crossref_primary_10_1517_14656566_2014_913570 crossref_primary_10_1097_GOX_0000000000000819 crossref_primary_10_1177_00031348231216487 crossref_primary_10_1002_jcb_30496 crossref_primary_10_1007_s15013_020_3026_9 crossref_primary_10_1186_s13046_022_02330_4 crossref_primary_10_1371_journal_pone_0143061 crossref_primary_10_1093_jjco_hyv185 crossref_primary_10_3109_07357907_2015_1065500 crossref_primary_10_1007_s40520_019_01312_5 crossref_primary_10_1016_j_canep_2025_102797 crossref_primary_10_1038_onc_2015_260 crossref_primary_10_1002_jcp_27445 crossref_primary_10_1016_j_jnutbio_2017_12_011 crossref_primary_10_1186_s40644_019_0227_3 crossref_primary_10_1007_s00604_020_04526_x crossref_primary_10_1007_s13193_020_01040_7 crossref_primary_10_1038_onc_2014_461 crossref_primary_10_1186_s12885_024_12129_5 crossref_primary_10_3945_an_115_009647 crossref_primary_10_1016_j_arabjc_2020_10_019 crossref_primary_10_1007_s00432_025_06122_z crossref_primary_10_1111_cbdd_12671 crossref_primary_10_1016_j_maturitas_2020_08_010 crossref_primary_10_1111_bju_12950 crossref_primary_10_1186_s13046_019_1069_3 crossref_primary_10_7759_cureus_64348 crossref_primary_10_1634_theoncologist_2016_0369 crossref_primary_10_1002_fsn3_70632 crossref_primary_10_1016_j_clbc_2016_04_001 crossref_primary_10_1186_s12957_024_03374_w crossref_primary_10_1371_journal_pone_0268060 crossref_primary_10_2147_IJN_S453958 crossref_primary_10_5858_arpa_2013_0763_ED crossref_primary_10_1002_cmdc_201800546 crossref_primary_10_1186_s40064_015_1394_8 crossref_primary_10_3390_molecules27113412 crossref_primary_10_1111_cas_12715 crossref_primary_10_1080_10837450_2021_2018457 crossref_primary_10_1155_2020_4243175 crossref_primary_10_1016_j_breast_2015_12_010 crossref_primary_10_2217_nnm_15_182 crossref_primary_10_1007_s13277_015_3469_0 crossref_primary_10_2147_OTT_S239134 crossref_primary_10_1186_s40064_016_1736_1 crossref_primary_10_1039_D0FO02362K crossref_primary_10_1080_09553002_2016_1254833 crossref_primary_10_1016_S1470_2045_14_70364_X crossref_primary_10_1016_j_bmcl_2021_127952 crossref_primary_10_1016_j_jcpo_2015_03_002 crossref_primary_10_1007_s10900_018_0490_4 crossref_primary_10_1007_s12282_020_01087_y crossref_primary_10_3892_ijo_2019_4869 crossref_primary_10_1093_bja_aew449 crossref_primary_10_3389_fgene_2021_628136 crossref_primary_10_1002_cncr_32430 crossref_primary_10_3892_ol_2016_5374 crossref_primary_10_5372_1905_7415_1004_494 crossref_primary_10_1111_ecc_13038 crossref_primary_10_1080_03639045_2018_1438462 crossref_primary_10_3892_mmr_2016_5881 crossref_primary_10_1016_j_clbc_2018_08_005 crossref_primary_10_1016_j_ctarc_2022_100605 crossref_primary_10_1038_srep13073 crossref_primary_10_1097_MNM_0000000000000576 crossref_primary_10_2147_JPR_S237435 crossref_primary_10_1016_j_arcmed_2016_11_001 crossref_primary_10_1007_s10549_014_3172_7 crossref_primary_10_3390_healthcare4030062 crossref_primary_10_3390_nu6115184 crossref_primary_10_1038_s41419_020_03308_w crossref_primary_10_3389_fonc_2019_00164 crossref_primary_10_1007_s10549_016_3692_4 crossref_primary_10_1016_j_cca_2018_07_004 crossref_primary_10_1038_s41598_020_61679_8 |
| Cites_doi | 10.1200/JCO.2008.19.6873 10.1200/JCO.2013.49.3122 10.3322/caac.20140 10.1002/cncr.23131 10.3322/caac.20121 10.1002/ijc.28222 10.1002/cncr.25589 10.1002/cncr.22786 10.1097/MLR.0b013e3181f380e0 10.1093/jnci/djs014 10.1056/NEJMoa050518 10.3945/ajcn.111.014415 10.1007/s10549-013-2434-0 10.1007/s10549-012-2396-7 10.1007/s10549-012-2089-2 10.1093/jnci/djq526 10.1001/archinte.166.20.2244 10.1056/NEJMsr070105 10.1001/jama.288.3.321 10.1002/cncr.25276 10.1016/j.ejca.2009.01.016 10.1093/jnci/djq345 10.5694/j.1326-5377.2008.tb01821.x 10.1007/s10552-009-9437-5 10.1158/1055-9965.EPI-08-0679 10.5858/134.7.e48 10.1089/jwh.2008.1127 10.1016/j.maturitas.2008.09.022 10.3322/caac.21166 10.1093/jnci/djr257 10.1093/jnci/djm059 10.1002/cncr.25679 10.1158/1055-9965.EPI-11-0061 10.1007/s10549-010-1191-6 10.1093/jnci/djh025 10.6004/jnccn.2010.0083 10.7326/0003-4819-158-8-201304160-00005 10.1016/j.maturitas.2012.04.013 |
| ContentType | Journal Article |
| Copyright | 2013 American Cancer Society, Inc. Copyright Wiley Subscription Services, Inc. Jan/Feb 2014 |
| Copyright_xml | – notice: 2013 American Cancer Society, Inc. – notice: Copyright Wiley Subscription Services, Inc. Jan/Feb 2014 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7T5 7TO 7U9 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 AZQEC BENPR CCPQU DWQXO FR3 FYUFA GHDGH GNUQQ GUQSH H94 K9. KB0 M0S M1P M2O MBDVC NAPCQ P64 PADUT PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI Q9U RC3 7X8 |
| DOI | 10.3322/caac.21203 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Immunology Abstracts Oncogenes and Growth Factors Abstracts Virology and AIDS Abstracts ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Technology Research Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland British Nursing Database ProQuest Central Essentials AUTh Library subscriptions: ProQuest Central ProQuest One Community College ProQuest Central Korea Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Research Library Research Library (Corporate) Nursing & Allied Health Premium Biotechnology and BioEngineering Abstracts Research Library China ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central Basic Genetics Abstracts MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts Technology Research Database ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) Research Library China ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Central Basic ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | CrossRef MEDLINE - Academic Research Library Prep MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7RV name: Nursing & Allied Health Database url: https://search.proquest.com/nahs sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1542-4863 |
| EndPage | 62 |
| ExternalDocumentID | 3190283481 24114568 10_3322_caac_21203 CAAC21203 |
| Genre | article Journal Article Review Feature |
| GeographicLocations | United States United States--US |
| GeographicLocations_xml | – name: United States – name: United States--US |
| GroupedDBID | .GA .GJ .Y3 0R~ 10A 18M 1CY 1OB 1OC 23N 24P 2WC 31~ 4.4 41~ 50Y 50Z 51W 51X 52M 52N 52P 52R 52S 52T 52X 53G 5GY 5RE 5VS 66C 6J9 6PF 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAEVG AAFWJ AAONW AAWTL AAZKR ABCQN ABEML ACBNA ACCMX ACGFO ACPRK ACSCC ACXQS ADBBV ADIZJ ADPDF ADXAS AEGXH AEIMD AFBPY AFFNX AFZJQ AHMBA AI. AIAGR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR ATUGU AZBYB BAFTC BAWUL BFHJK BKOMP BY8 C1A CS3 D-6 D-7 D-E D-F DCZOG DIK DR2 E3Z EBD EBS EIHBH EJD EMB EMOBN F00 F01 F04 F5P FAS FJW G-S GODZA GX1 H.X HZ~ IX1 J0M KQ8 L7B LC2 LC3 LH4 LW6 N04 N05 NF~ O66 O9- OHT OK1 OVD OVT P2P P2W P2X P2Z PQQKQ Q.N Q11 QB0 ROL RWL RX1 RXW SJN SUPJJ SV3 TAE TEORI TR2 TWZ UB1 UDS VH1 W2D W8V WH7 WHWMO WIN WOHZO WOQ WQJ WVDHM WXI XG1 XSB XV2 XZL YQJ ZCG ZGI ZVN ZXP ~WT AAYXX CITATION O8X CGR CUY CVF ECM EIF NPM 3V. 7RV 7T5 7TO 7U9 7X7 7XB 88E 8AO 8FD 8FI 8FJ 8FK 8G5 ABUWG AFKRA AN0 AZQEC BENPR CCPQU DWQXO FR3 FYUFA GNUQQ GUQSH H94 K9. M1P M2O MBDVC NAPCQ P64 PADUT PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQUKI Q9U RC3 7X8 |
| ID | FETCH-LOGICAL-c4593-708433f9db7069cb0f16f309ee60bfd68281b95a0a90a1f0222bbfd344c6c8173 |
| IEDL.DBID | 24P |
| ISICitedReferencesCount | 1763 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000329734100006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 0007-9235 1542-4863 |
| IngestDate | Thu Oct 02 06:54:38 EDT 2025 Fri Oct 03 02:51:21 EDT 2025 Mon Jul 21 05:36:51 EDT 2025 Sat Nov 29 06:55:07 EST 2025 Tue Nov 18 21:46:56 EST 2025 Sun Sep 21 06:19:47 EDT 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | epidemiology health disparities screening and early detection breast neoplasms |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor 2013 American Cancer Society, Inc. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4593-708433f9db7069cb0f16f309ee60bfd68281b95a0a90a1f0222bbfd344c6c8173 |
| Notes | The authors report no conflicts of interest. DISCLOSURES SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 14 ObjectType-Article-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://onlinelibrary.wiley.com/doi/pdfdirect/10.3322/caac.21203 |
| PMID | 24114568 |
| PQID | 1491427581 |
| PQPubID | 6515 |
| PageCount | 11 |
| ParticipantIDs | proquest_miscellaneous_1490711324 proquest_journals_1491427581 pubmed_primary_24114568 crossref_primary_10_3322_caac_21203 crossref_citationtrail_10_3322_caac_21203 wiley_primary_10_3322_caac_21203_CAAC21203 |
| PublicationCentury | 2000 |
| PublicationDate | January/February 2014 |
| PublicationDateYYYYMMDD | 2014-01-01 |
| PublicationDate_xml | – month: 01 year: 2014 text: January/February 2014 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: Atlanta |
| PublicationTitle | CA: a cancer journal for clinicians |
| PublicationTitleAlternate | CA Cancer J Clin |
| PublicationYear | 2014 |
| Publisher | Wiley Subscription Services, Inc |
| Publisher_xml | – name: Wiley Subscription Services, Inc |
| References | 2009; 45 2013; 1 2011; 117 2005; 353 2013; 63 2010; 102 2011; 61 2008; 188 2012; 104 2007; 99 2009; 27 2012; 95 2007; 356 2012; 72 2011; 127 2011; 103 2010; 21 2004; 96 2012; 134 2010; 116 2013; 138 2007; 110 2013; 137 2010; 134 2013; 31 2002; 288 2011; 20 2013; 158 2013 2008; 61 2008; 112 2011; 49 2006; 166 2009; 18 2012; 62 2010; 8 e_1_2_5_27_1 e_1_2_5_25_1 e_1_2_5_48_1 e_1_2_5_23_1 e_1_2_5_46_1 e_1_2_5_21_1 e_1_2_5_44_1 e_1_2_5_29_1 e_1_2_5_42_1 e_1_2_5_40_1 (e_1_2_5_14_1) 2013 e_1_2_5_15_1 e_1_2_5_38_1 e_1_2_5_17_1 e_1_2_5_36_1 e_1_2_5_11_1 e_1_2_5_34_1 e_1_2_5_7_1 e_1_2_5_32_1 e_1_2_5_3_1 e_1_2_5_19_1 Howlader N (e_1_2_5_5_1) 2013 e_1_2_5_30_1 e_1_2_5_28_1 e_1_2_5_49_1 e_1_2_5_26_1 e_1_2_5_47_1 e_1_2_5_24_1 e_1_2_5_45_1 e_1_2_5_22_1 e_1_2_5_43_1 (e_1_2_5_13_1) 2013 e_1_2_5_20_1 e_1_2_5_41_1 e_1_2_5_39_1 e_1_2_5_16_1 e_1_2_5_37_1 e_1_2_5_8_1 e_1_2_5_10_1 e_1_2_5_35_1 e_1_2_5_6_1 e_1_2_5_12_1 e_1_2_5_33_1 e_1_2_5_4_1 e_1_2_5_2_1 e_1_2_5_18_1 Copeland G (e_1_2_5_9_1) 2013 e_1_2_5_31_1 e_1_2_5_50_1 |
| References_xml | – volume: 137 start-page: 869 year: 2013 end-page: 882 article-title: Physical activity and risk of breast cancer: a meta‐analysis of prospective studies publication-title: Breast Cancer Res Treat – volume: 188 start-page: 641 year: 2008 end-page: 644 article-title: Decrease in breast cancer incidence following a rapid fall in use of hormone replacement therapy in Australia publication-title: Med J Aust – volume: 134 start-page: e48 year: 2010 end-page: e72 article-title: American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version) publication-title: Arch Pathol Lab Med – volume: 99 start-page: 1152 year: 2007 end-page: 1161 article-title: Breast cancer incidence, 1980‐2006: combined roles of menopausal hormone therapy, screening mammography, and estrogen receptor status publication-title: J Natl Cancer Inst – volume: 31 start-page: 2942 year: 2013 end-page: 2962 article-title: Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline publication-title: J Clin Oncol – volume: 103 start-page: 1397 year: 2011 end-page: 1402 article-title: Incidence of breast cancer in the United States: current and future trends publication-title: J Natl Cancer Inst – volume: 158 start-page: 604 year: 2013 end-page: 614 article-title: Use of medications to reduce risk for primary breast cancer: a systematic review for the U.S. Preventive Services Task Force publication-title: Ann Intern Med – volume: 27 start-page: 4515 year: 2009 end-page: 4521 article-title: Population differences in breast cancer: survey in indigenous African women reveals over‐representation of triple‐negative breast cancer publication-title: J Clin Oncol – volume: 1 year: 2013 – volume: 95 start-page: 713 year: 2012 end-page: 725 article-title: Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies publication-title: Am J Clin Nutr – volume: 8 start-page: 1112 year: 2010 end-page: 1146 article-title: Breast cancer risk reduction publication-title: J Natl Compr Canc Netw – volume: 134 start-page: 875 year: 2012 end-page: 880 article-title: Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010 publication-title: Breast Cancer Res Treat – volume: 356 start-page: 1670 year: 2007 end-page: 1674 article-title: The decrease in breast‐cancer incidence in 2003 in the United States publication-title: N Engl J Med – volume: 21 start-page: 83 year: 2010 end-page: 90 article-title: The impact of changes in hormone therapy on breast cancer incidence in the US population publication-title: Cancer Causes Control – volume: 72 start-page: 317 year: 2012 end-page: 323 article-title: Update of the evolution of breast cancer incidence in relation to hormone replacement therapy use in Belgium publication-title: Maturitas – volume: 103 start-page: 250 year: 2011 end-page: 263 article-title: Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies publication-title: J Natl Cancer Inst – volume: 18 start-page: 883 year: 2009 end-page: 893 article-title: The influence of socioeconomic disparities on breast cancer tumor biology and prognosis: a review publication-title: J Womens Health (Larchmt) – volume: 45 start-page: 1649 year: 2009 end-page: 1653 article-title: Is the recent fall in incidence of post‐menopausal breast cancer in UK related to changes in use of hormone replacement therapy? publication-title: Eur J Cancer. – volume: 18 start-page: 121 year: 2009 end-page: 131 article-title: Trends in area‐socioeconomic and race‐ethnic disparities in breast cancer incidence, stage at diagnosis, screening, mortality, and survival among women ages 50 years and over (1987‐2005) publication-title: Cancer Epidemiol Biomarkers Prev – volume: 288 start-page: 321 year: 2002 end-page: 333 article-title: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial publication-title: JAMA – volume: 117 start-page: 2209 year: 2011 end-page: 2218 article-title: Update on mammography trends: comparisons of rates in 2000, 2005, and 2008 publication-title: Cancer – volume: 110 start-page: 403 year: 2007 end-page: 411 article-title: Insurance status and stage of cancer at diagnosis among women with breast cancer publication-title: Cancer – volume: 166 start-page: 2244 year: 2006 end-page: 2252 article-title: Delays in breast cancer diagnosis and treatment by racial/ethnic group publication-title: Arch Intern Med – volume: 117 start-page: 1542 year: 2011 end-page: 1551 article-title: Socioeconomic status and survival after an invasive breast cancer diagnosis publication-title: Cancer – volume: 20 start-page: 733 year: 2011 end-page: 739 article-title: Breast cancer incidence rates in U.S. women are no longer declining publication-title: Cancer Epidemiol Biomarkers Prev – volume: 138 start-page: 633 year: 2013 end-page: 641 article-title: A trend analysis of breast cancer incidence rates in the United States from 2000 to 2009 shows a recent increase publication-title: Breast Cancer Res Treat – volume: 127 start-page: 729 year: 2011 end-page: 738 article-title: Disparities in breast cancer characteristics and outcomes by race/ethnicity publication-title: Breast Cancer Res Treat – volume: 61 start-page: 212 year: 2011 end-page: 236 article-title: Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths publication-title: CA Cancer J Clin – article-title: Anderson WF, Rosenberg PS, Petito L, et al. Divergent estrogen receptor‐positive and ‐negative breast cancer trends and etiologic heterogeneity in Denmark [published online ahead of print April 24, 2013] publication-title: Int J Cancer. – volume: 96 start-page: 218 year: 2004 end-page: 228 article-title: Risk factors for breast cancer according to estrogen and progesterone receptor status publication-title: J Natl Cancer Inst – volume: 102 start-page: 1489 year: 2010 end-page: 1495 article-title: Breast cancer incidence and hormone replacement therapy in Canada publication-title: J Natl Cancer Inst – volume: 49 start-page: 67 year: 2011 end-page: 75 article-title: Accuracy of diagnostic mammography at facilities serving vulnerable women publication-title: Med Care – volume: 116 start-page: 4926 year: 2010 end-page: 4932 article-title: African ancestry and higher prevalence of triple‐negative breast cancer: findings from an international study publication-title: Cancer – volume: 353 start-page: 1784 year: 2005 end-page: 1792 article-title: Effect of screening and adjuvant therapy on mortality from breast cancer publication-title: N Engl J Med – volume: 63 start-page: 11 year: 2013 end-page: 30 article-title: Cancer statistics, 2013 publication-title: CA Cancer J Clin – volume: 61 start-page: 299 year: 2008 end-page: 304 article-title: Postmenopausal hormone drugs and breast and colon cancer: Nordic countries 1995‐2005 publication-title: Maturitas – volume: 104 start-page: 517 year: 2012 end-page: 527 article-title: Changing concepts: menopausal hormone therapy and breast cancer publication-title: J Natl Cancer Inst – volume: 62 start-page: 30 year: 2012 end-page: 67 article-title: American Cancer Society Guidelines on nutrition and physical activity for cancer prevention: reducing the risk of cancer with healthy food choices and physical activity publication-title: CA Cancer J Clin – volume: 112 start-page: 171 year: 2008 end-page: 180 article-title: Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? publication-title: Cancer. – year: 2013 – ident: e_1_2_5_28_1 doi: 10.1200/JCO.2008.19.6873 – ident: e_1_2_5_49_1 doi: 10.1200/JCO.2013.49.3122 – ident: e_1_2_5_45_1 doi: 10.3322/caac.20140 – ident: e_1_2_5_39_1 doi: 10.1002/cncr.23131 – ident: e_1_2_5_37_1 doi: 10.3322/caac.20121 – ident: e_1_2_5_11_1 – ident: e_1_2_5_29_1 doi: 10.1002/ijc.28222 – ident: e_1_2_5_40_1 doi: 10.1002/cncr.25589 – ident: e_1_2_5_41_1 doi: 10.1002/cncr.22786 – ident: e_1_2_5_4_1 – ident: e_1_2_5_43_1 doi: 10.1097/MLR.0b013e3181f380e0 – ident: e_1_2_5_46_1 doi: 10.1093/jnci/djs014 – ident: e_1_2_5_36_1 doi: 10.1056/NEJMoa050518 – ident: e_1_2_5_34_1 doi: 10.3945/ajcn.111.014415 – ident: e_1_2_5_30_1 doi: 10.1007/s10549-013-2434-0 – ident: e_1_2_5_10_1 – ident: e_1_2_5_35_1 doi: 10.1007/s10549-012-2396-7 – ident: e_1_2_5_50_1 doi: 10.1007/s10549-012-2089-2 – ident: e_1_2_5_8_1 – ident: e_1_2_5_25_1 doi: 10.1093/jnci/djq526 – ident: e_1_2_5_44_1 doi: 10.1001/archinte.166.20.2244 – ident: e_1_2_5_16_1 doi: 10.1056/NEJMsr070105 – ident: e_1_2_5_2_1 – ident: e_1_2_5_15_1 doi: 10.1001/jama.288.3.321 – ident: e_1_2_5_27_1 doi: 10.1002/cncr.25276 – ident: e_1_2_5_20_1 doi: 10.1016/j.ejca.2009.01.016 – ident: e_1_2_5_24_1 doi: 10.1093/jnci/djq345 – volume-title: SEER Cancer Statistics Review, 1975‐2010 year: 2013 ident: e_1_2_5_5_1 – ident: e_1_2_5_23_1 doi: 10.5694/j.1326-5377.2008.tb01821.x – ident: e_1_2_5_17_1 doi: 10.1007/s10552-009-9437-5 – ident: e_1_2_5_42_1 doi: 10.1158/1055-9965.EPI-08-0679 – ident: e_1_2_5_32_1 doi: 10.5858/134.7.e48 – ident: e_1_2_5_26_1 doi: 10.1089/jwh.2008.1127 – volume-title: Joinpoint Regression Program, Version 4.0.4 year: 2013 ident: e_1_2_5_13_1 – ident: e_1_2_5_22_1 doi: 10.1016/j.maturitas.2008.09.022 – ident: e_1_2_5_12_1 doi: 10.3322/caac.21166 – ident: e_1_2_5_6_1 doi: 10.1093/jnci/djr257 – ident: e_1_2_5_7_1 – ident: e_1_2_5_31_1 doi: 10.1093/jnci/djm059 – volume-title: DevCan: Probability of Developing or Dying of Cancer Software. Version 6.7.0 year: 2013 ident: e_1_2_5_14_1 – ident: e_1_2_5_19_1 doi: 10.1002/cncr.25679 – ident: e_1_2_5_18_1 doi: 10.1158/1055-9965.EPI-11-0061 – ident: e_1_2_5_38_1 doi: 10.1007/s10549-010-1191-6 – ident: e_1_2_5_33_1 doi: 10.1093/jnci/djh025 – ident: e_1_2_5_48_1 doi: 10.6004/jnccn.2010.0083 – ident: e_1_2_5_3_1 – ident: e_1_2_5_47_1 doi: 10.7326/0003-4819-158-8-201304160-00005 – volume-title: Cancer In North America: 2006‐2010 year: 2013 ident: e_1_2_5_9_1 – ident: e_1_2_5_21_1 doi: 10.1016/j.maturitas.2012.04.013 |
| SSID | ssj0000777 |
| Score | 2.642584 |
| SecondaryResourceType | review_article |
| Snippet | In this article, the American Cancer Society provides an overview of female breast cancer statistics in the United States, including data on incidence,... |
| SourceID | proquest pubmed crossref wiley |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 52 |
| SubjectTerms | Adult African Americans Aged Breast cancer breast neoplasms Breast Neoplasms - epidemiology Breast Neoplasms - ethnology Breast Neoplasms - mortality epidemiology Estrogens Ethnicity Female health disparities Humans Incidence Medical screening Middle Aged Mortality Receptors, Estrogen - analysis screening and early detection Time Factors United States - epidemiology |
| SummonAdditionalLinks | – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT8MwDLZgQ4gL70dhTEVwAREtXdKmOaFt2sQBpgkB2q1q0vaEtrEHvx-nTTch0C7cqjZSLNuxPyfpZ4AbnqETcamI6V9NuGimRKlAEQyYfqwyzeKcp-D9SfT74XAoB3bDbWavVZYxMQ_UyVibPfIGInmPNxHdeg-TT2K6RpnTVdtCYxOqhqmMV6Da7vYHL6tYLETBmkkFQSjjFwSlDL24oWMUGAN32S6rTEm_cOZP2Jrnnd7efyXeh12LON1W4SIHsJGODmH72Z6pH0G9be6lz11t7D91zR9GBXnzvYtpmx3DW6_72nkktmsC0dyXjAgacsYymShBA6kVzbwADSLTNKAqSwIssTwl_ZjGksZeZgo-he8Z5zrQoSfYCVRG41F6Bi7nTCd-KlQz1jxLEOsFgVSICHST-iH1HbgtFRdpSyluOlt8RFhaGCVHRslRrmQHrpdjJwWRxp-jaqUuI7uYZtFKkQ5cLT_jMjBnG_EoHS_yMQiWsLTmDpwWdltOgyDFQ5wYOnCXG3LN_FGn1erkT-frJbmAHbQBLzZjalCZTxfpJWzpLzTRtG7d8Bt0Kt-1 priority: 102 providerName: ProQuest |
| Title | Breast cancer statistics, 2013 |
| URI | https://onlinelibrary.wiley.com/doi/abs/10.3322%2Fcaac.21203 https://www.ncbi.nlm.nih.gov/pubmed/24114568 https://www.proquest.com/docview/1491427581 https://www.proquest.com/docview/1490711324 |
| Volume | 64 |
| WOSCitedRecordID | wos000329734100006&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVWIB databaseName: Wiley Online Library Free Content customDbUrl: eissn: 1542-4863 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000777 issn: 0007-9235 databaseCode: WIN dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell – providerCode: PRVWIB databaseName: Wiley-Blackwell Open Access Collection customDbUrl: eissn: 1542-4863 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0000777 issn: 0007-9235 databaseCode: 24P dateStart: 19970101 isFulltext: true titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html providerName: Wiley-Blackwell |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD6IE_HF-6VeRkVfFItJkzYN-LINRUHnEJ17K0naPkknc_P3e5J2E1EE8SX0ckKanEu-kzTnABzzAoWISx3Y_NUBF2EeaB3rAA1mpHRhmHJxCvq3ottNBgPZm4OL6VmYKj7EbMHNaoaz11bBlXZZSBjKIDLRKGwQDa8N9dmglCU2cUPIe592WIgqYiYRAcKYqApOamuff9b9Oh19w5hfIaubc65W_ve1q7BcY02_VQnHGszl5Tos3tW76RvQbNs_0se-sZwf-fZsURW2-czHCZttwtPV5WPnOqjzJQSGR5IFgiScsUJmWpBYGk0KGiMrZJ7HRBdZjM4V1TJSREmiaGFdPY3PGecmNgkVbAvmy2GZ74DPOTNZlAsdKsOLDFFeHEuNWMCEJEpI5MHJdNhSUwcTtzktXlJ0KmyXU9vh1HXYg6MZ7WsVQuNHqv3p6Ke1Gr2hXyIpD9GloR4czl6jAthdDVXmw4mjQZiETjX3YLvi2qwZhCcUEWLiwaljzi_tp51Wq-Oudv9CvAdLyBFeLcrsw_x4NMkPYMG8I8NGTSeQWIqHvi0HwpVJExrty27vAe_uwnssn2-6H3O64uQ |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V25TsQwEB1xCWi4j3AGAQUICyd24rhAaFlAIJaFAtB2IXacCu3Ccomf4hsZ51iEQHQUdFFixZbfzPiNPZ4B2OAZChGXitj61YQL3xClQkXQYAaJyjRL8jwFNw3RbEatlrzsg_fqLowNq6xsYm6o0462e-S7yOQ97iO79fbvH4itGmVPV6sSGoVYnJm3V3TZHvdODxHfTd8_Prqqn5CyqgDRPJCMCBpxxjKZKkFDqRXNvBAHLI0JqcrSEF0QT8kgoYmkiZdZh0jhe8a5DnXkCYb_7YdBbjOL2VBB_-LT8gtR5OikgiBxCop0qAx1ZlcnOD24TFTFuaoF8Bur_UqS81XuePy_zc8EjJV82q0VCjAJfaY9BcPnZcTANKwc2Kj7J1db6e669v5UkZp6x0VSwmbg-k9GNwsD7U7bzIPLOdNpYITyE82zFJlsGEqFfEf7NIho4MBWBVSsy4Tptm7HXYyOkwU1tqDGOagOrPfa3hdpQn5stVRhF5em4jH-BM6Btd5nVHJ7cpO0Tec5b4NU0EPy68BcISe9bpCCeciCIwe2c8H5pf-4XqvV86eF30eyCiMnV-eNuHHaPFuEUcSDF9tOSzDw1H02yzCkXxCu7kquAC7c_rVEfQBPMDmo |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1bS8MwFD7IlOGL90t1zoq-KAbTJm2axzkdinPsQWVvpUnTJ-nG3Pz9nrTdxlAE8a20J6TJueQ7uXwBuOAZGhGXitj7qwkXviFKhYpgwAwSlWmWFDwFb13R60WDgexXe3PsWZiSH2I-4WY9o4jX1sHNKM2slzM0QtSiTrBGjLyW63OVB8KzRu3z_iIQC1FSZlJBEMcEJTupLX2zKLs8Hn0DmcuYtRh0Opv__N0t2KjQptsqzWMbVky-A_Xnaj19F5q3dk_6xNVW92PXni4qiZuvXRyy2R68du5f2g-kujGBaB5IRgSNOGOZTJWgodSKZl6IypDGhFRlaYjpladkkNBE0sTLbLKn8D3jXIc68gTbh1o-zM0huJwznQZGKD_RPEsR54WhVIgGtE-DiAYOXM76LdYVnbi91eI9xrTCNjm2DY6LBjtwPpcdlSQaP0o1Zt0fV470gZmJ9LiPSY3nwNn8M7qAXddIcjOcFjIIlDCt5g4clGqbV4MAxUOMGDlwVWjnl_rjdqvVLp6O_iJ8CvX-XSfuPvaejmEdlcPLGZoG1CbjqTmBNf2Juhs3C-P8AlWX3-w |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Breast+cancer+statistics%2C+2013&rft.jtitle=CA%3A+a+cancer+journal+for+clinicians&rft.au=DeSantis%2C+Carol&rft.au=Ma%2C+Jiemin&rft.au=Bryan%2C+Leah&rft.au=Jemal%2C+Ahmedin&rft.date=2014-01-01&rft.issn=0007-9235&rft.eissn=1542-4863&rft.volume=64&rft.issue=1&rft.spage=52&rft.epage=62&rft_id=info:doi/10.3322%2Fcaac.21203&rft.externalDBID=n%2Fa&rft.externalDocID=10_3322_caac_21203 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0007-9235&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0007-9235&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0007-9235&client=summon |